Regencell Bioscience Holdings Limited Ordinary Shares

RGC XNAS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

2.8B

Short interest (Jul 15)

0.2%

Net Short (Jul 27 ): 0.0%

Borrow Fee

301.75%

↑ 7.8%

Available Shares

↓ 40.2%

Price Chart

Company Overview

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Company Info

Exchange: NASDAQ

CIK: 0001829667

Asset Type: CS

Market Data

Market Cap: $2,828,476,553

Employees: 10

Status: Active

Short Interest

Current Borrow Fee 301.75%

Range: 301.75% - 301.75%

Available Shares 0

Range: 0 - 10K

Recent Changes

Fee Change: ↑ 22.7%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime